Results 241 to 250 of about 15,045 (253)

Amodiaquine Resistant Falciparum Malaria in Thailand

The American Journal of Tropical Medicine and Hygiene, 1975
Amodiaquine cured 38% (13/34) of patients with falciparum malaria in Southeast Thailand. Chloroquine cured 0% (0/13). The cure rates with amodiaquine were the same whether a 1.5 g or 2.0 g course was used. Most patients were resistant to amodiaquine at the RI level and to chloroquine at the RII level.
P. Phintuyothin, A.P. Hall, Herbert E. Segal, S. Kosakal, Eliot J. Pearlman   +4 more
openaire   +3 more sources

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

The Lancet, 2005
Many countries in Africa are considering a change to combination treatment for falciparum malaria because of the increase in drug resistance. However, there are few effectiveness data for these combinations. Our aim was to study the effectiveness of three drug combinations that have proven efficacious in east Africa compared with amodiaquine ...
Rachel Hallett, Jalal Uddin Ahmed, Chris Drakeley, Archie Heller, Christopher J. M. Whitty, Brian Greenwood, Devota Anthony, Theonest K. Mutabingwa, Theonest K. Mutabingwa   +8 more
openaire   +3 more sources

The safety of amodiaquine use in pregnant women

Expert Opinion on Drug Safety, 2007
Few antimalarial drugs have been evaluated extensively in pregnancy because of fears over toxicity. However, increasing Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine makes finding alternative antimalarials that are safe and effective in pregnancy a priority.
Daniel Chandramohan, Brian Greenwood, Harry Tagbor   +2 more
openaire   +3 more sources

Amodiaquine and Hydroxychloroquine Resistance in Plasmodium falciparum

The American Journal of Tropical Medicine and Hygiene, 1961
Summary and Conclusions A strain of Plasmodium falciparum from the Magdalena Valley, Colombia, South America, which is resistant to chloroquine, has been shown to be resistant also to amodiaquine (Camoquin®) and to hydroxychloroquine (Plaquenil®), which are other members of the 4-aminoquinoline group.
openaire   +3 more sources

Unusual Toxic Manifestations to Amodiaquin (Camoquin)

Archives of Dermatology, 1958
A 42-year-old white woman, with chronic, discoid lupus erythematosus of 12 years' duration, was found to be intolerant (acute gastroenteritis) of all previously tried antimalarials. Because of recent reports 1 on the use of amodiaquin (Camoquin) it was felt judicious to institute such therapy in this patient.
openaire   +3 more sources

Amodiaquine during pregnancy

The Lancet Infectious Diseases, 2004
Anders Björkman, Abdullah S. Ali, Achuyt Bhattarai, Mita Maini-Thapar   +3 more
openaire   +3 more sources

AMODIAQUINE-RESISTANT MALARIA IN BRAZIL

The Lancet, 1987
Peter G. Kremsner, G.M. Zotter, W. Grainger, Hermann Feldmeier   +3 more
openaire   +3 more sources

AMODIAQUINE AND HYDROXYCHLOROQUINE IN RHEUMATOID ARTHRITIS

The Lancet, 1959
A.G. Palin, G.D. Kersley
openaire   +3 more sources

Oro-Facial Dyskinesias and Amodiaquine

Therapies, 2004
Mamadou Kamagaté, Eric Balayssac, Potey-Thérèse Daubret, Jean-Claude Yavo, Henri Die-Kacou   +4 more
openaire   +2 more sources

Amodiaquine in malaria treatment

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1987
openaire   +3 more sources